Status:
TERMINATED
Carbohydrates Under Target for Type 1 Diabetes Management
Lead Sponsor:
McGill University
Conditions:
Type 1 Diabetes
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Recently there has been an increased interest in limiting intake of carbohydrates (CHO) for improving long term health. While healthcare professionals (HCPs) are sometimes reluctant to limit the CHO i...
Eligibility Criteria
Inclusion
- Duration of Type 1 Diabetes \> 12 months
- On intensive insulin therapy for \> 6 months
- Own a smartphone or tablet to use two mobile applications : Keenoa and Piezo: Achieve the Guidelines!
Exclusion
- Known gastroparesis (clinical diagnosis)
- Advanced kidney disease (eGFR \< 50 mL/min)
- Known significant liver disease (e.g., cirrhosis, active hepatitis, liver transplantation)
- Recent (\< 6 months) major cardiovascular even (e.g. myocardial infarction, cerebrovascular accident, major revascularization, etc.)
- Pregnancy (ongoing or planned in the next 6 months)
- Breastfeeding
- Severe hypoglycemia episodes or ketoacidosis in the 4 weeks prior to recruitment
- Claustrophobia or presence of metal devices/implants in the body
Key Trial Info
Start Date :
October 15 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 23 2020
Estimated Enrollment :
8 Patients enrolled
Trial Details
Trial ID
NCT04084418
Start Date
October 15 2019
End Date
March 23 2020
Last Update
February 24 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Institut de recherches cliniques de Montréal
Montreal, Quebec, Canada, H2W1R7